Page last updated: 2024-09-03

imatinib mesylate and Atherosclerotic Parkinsonism

imatinib mesylate has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, H; He, Q; Huang, Q; Li, M; Liu, Q; Ma, J; Wu, R; Yuan, Z1

Other Studies

1 other study(ies) available for imatinib mesylate and Atherosclerotic Parkinsonism

ArticleYear
c-Abl-p38α signaling plays an important role in MPTP-induced neuronal death.
    Cell death and differentiation, 2016, Volume: 23, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acid Sequence; Animals; Cell Death; Dopaminergic Neurons; Enzyme Activation; Female; HEK293 Cells; Humans; Imatinib Mesylate; Male; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinase 14; Molecular Sequence Data; Oxidative Stress; Parkinson Disease, Secondary; Phosphorylation; Protein Binding; Protein Interaction Maps; Protein Multimerization; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-abl; Signal Transduction

2016